Abstract:Background: Upon allergen challenge, food allergy typically leads to mast cell degranulation, an influx of Th2 cells together with increases in antigen specific antibodies. Currently, there is no treatment available. Vagal nerve stimulation has immune-suppressive effects on innate immune responses. Here we tested whether vagal nerve stimulation could dampen adaptive immune responses as seen in food allergy. Methods: Balb/c mice were sensitized to ovalbumin adsorbed to aluminium-hydroxide (day 0 and 14) followed by four intra-gastric gavages with ovalbumin, from day 28 onwards. The vagal nerve was stimulated at the cervical level (5V 5Hz 1ms 5mins) prior to each gavage, controls received sham surgery. Antibody titres (ovalbumin specific IgG1, IgG2a and IgE), mouse mast cell protease 1, (MMCP-1) released into the circulation were determined and regulatory T cells (Tregs) were enumerated in the mesenteric lymph nodes (MLN). In addition, mucosal barrier function was assessed in Ussing chambers (passage of FITC-Dextran 40kDa) and gastro-intestinal transit was determined by determining the geometric centre 90 min after i.g. administration of FITC-Dextran 70kDa. Results: Ovalbumin challenge resulted in increased levels of serum MMCP-1 and ovalbuminspecific IgG1, IgG2a and IgE. Vagal nerve stimulation significantly reduced MMCP-1 (from 4038 ± 907 to 1093 ± 436 ng/mL (n=8, p=0.01) and serum IgG2a (as measured by relative serum dilutions, 2-way ANOVA F(7,84)=5.61 p<0.0001)(t=1hr after ovalbumin challenge). The percentage of mesenteric lymph nodes Tregs significantly increased in vagal nerve stimulated mice when compared to sham mice (from 10.2 ± 0.3 to 12.3 ± 0.2% CD25+/ foxp3+ of CD4 cells, p< 0.0001), whereas the total number of T-cells remained unaffected. Vagal nerve stimulation improved the mucosal barrier (passage the ovalbumin-sized FD40 improved from 129.7 ± 46.7 to 48.5 ± 5.2 pmol FD40/cm2 18hrs after ovalbumin gavage (p<0.05, n=7/8) and reversed food allergy-induced delay in gastro-intestinal transit (GC improved from 3.3 ± 0.4 to 5.1 ± 0.3, P<0.02). Conclusion: We showed that vagal nerve stimulation reduced mast cell activation and IgG2a production evoked by antigen challenge and improved barrier function and gastrointestinal transit in a model of food allergy. These data suggest that in addition to modulation of the innate immune system the vagus nerve is able to modulate the adaptive immune system, possibly by induction of Tregs. Further studies are required to unravel the underlying mechanism of action and should ultimately reveal novel drug targets to improve treatment of patients with food allergy.

878 Rifaximin Prevents Intestinal Inflammation and Improves Gut Barrier Function by Modulating Gut Microbiomes in Chronically Stressed Rats: Therapeutic Implications in IBS